Indeksa Nr.

Starptautiskā ķīmiskā identifikācija

EK Nr.

CAS Nr.

Klasifikācija

Marķējums

Specifiskās robežkoncentrācijas, m koeficients

Piezīmes

Bīstamības klases un kategorijas kodi

Bīstamības apzīmējuma kodi

Piktogramma, signālvārda kodi

Bīstamības apzīmējuma kodi

Papildu bīstamības apzīmējuma kodi

007-004-00-1

… % slāpekļskābe

231-714-2

7697-37-2

Ox. Liq. 2

Skin Corr. 1A

H272

H314

GHS03

GHS05

Dgr

H272

H314

EUH071

Skin Corr. 1A; H314: C ≥ 20 %

Skin Corr. 1B; H314: 5 % ≤ C < 20 %

Ox. Liq. 2; H272: C ≥ 99 %

Ox. Liq. 3; H272: 99 % > C ≥ 65 %

B

015-003-00-2

kalcija fosfīds; trikalcija difosfīds

215-142-0

1305-99-3

Water-react. 1

Acute Tox. 2

Acute Tox. 3

Acute Tox. 1

Eye Dam. 1

Aquatic Acute 1

H260

H300

H311

H330

H318

H400

GHS02

GHS06

GHS05

GHS09

Dgr

H260

H300

H311

H330

H318

H400

EUH029

EUH032

M = 100

031-001-00-4

gallija arsenīds

215-114-8

1303-00-0

Repr. 1B

Carc. 1B

STOT RE 1

H360F

H350

H372 (respiratorā un hematopoētiskā sistēma)

GHS08

Dgr

H360F

H350

H372 (respiratorā un hematopoētiskā sistēma)

050-008-00-3

tributilalvas savienojumi, kas nav minēti citur šajā pielikumā

—

—

Repr. 1B

Acute Tox. 3

Acute Tox. 4*

STOT RE 1

Skin Irrit. 2

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H360FD

H301

H312

H372**

H315

H319

H400

H410

GHS08

GHS06

GHS09

Dgr

H360FD

H301

H312

H372**

H315

H319

H410

*

STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,25 % ≤ C < 1 %

Skin Irrit. 2; H315:C ≥ 1 %

Eye Irrit. 2; H319:C ≥ 1 %

M = 10

A

1

603-102-00-9

1,2-epoksibutāns

203-438-2

106-88-7

Flam. Liq. 2

Carc. 2

Acute Tox. 4*

Acute Tox. 4*

Acute Tox. 4*

STOT SE 3

Skin Irrit. 2

Eye Irrit. 2

H225

H351

H302

H312

H332

H335

H315

H319

GHS02

GHS08

GHS07

Dgr

H225

H351

H302

H312

H332

H335

H315

H319

603-197-00-7

tebukonazols (ISO); 1-(4-hlorfenil)-4,4-dimetil-3-(1,2,4-triazol-1-ilmetil)pentan-3-ols

403-640-2

107534-96-3

Repr. 2

Acute Tox. 4

Aquatic Acute 1

Aquatic Chronic 1

H361d***

H302

H400

H410

GHS08

GHS07

GHS09

Wng

H361d***

H302

H410

M = 1

M = 10

606-054-00-7

izoksaflutols (ISO); 5-ciklopropil-1,2-oksazol-4-il α,α,α-trifluor-2-mezil-p-toluil ketons

—

141112-29-0

Repr. 2

Aquatic Acute 1

Aquatic Chronic 1

H361d***

H400

H410

GHS08

GHS09

Wng

H361d***

H410

M = 10

M = 100

607-197-00-8

nonānskābe

203-931-2

112-05-0

Skin Irrit. 2

Eye Irrit. 2

Aquatic Chronic 3

H315

H319

H412

GHS07

Wng

H315

H319

H412

613-042-00-5

imazalils (ISO); 1-[2-(aliloksi)-2-(2,4-dihlorfenil)etil]-1H-imidazols

252-615-0

35554-44-0

Carc. 2

Acute Tox. 3

Acute Tox. 4

Eye Dam. 1

Aquatic Chronic 1

H351

H301

H332

H318

H410

GHS08

GHS06

GHS05

GHS09

Dgr

H351

H301

H332

H318

H410

M = 10

613-057-00-7

dodemorfs (ISO); 4-ciklododecil-2,6-dimetilmorfolīns

216-474-9

1593-77-7

Repr. 2

STOT RE 2

Skin Corr. 1C

Skin Sens. 1A

Aquatic Acute 1

Aquatic Chronic 1

H361d

H373 (aknas)

H314

H317

H400

H410

GHS08

GHS05

GHS07

GHS09

Dgr

H361d

H373 (aknas)

H314

H317

H410

EUH071

M = 1

M = 1

613-133-00-X

etridiazols (ISO); 5-etoksi-3-trihlormetil-1,2,4-tiadiazols

219-991-8

2593-15-9

Carc. 2

Acute Tox. 4

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H302

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H302

H317

H410

M = 1

M = 1

613-149-00-7

piridabēns (ISO); 2-terc-butil-5-(4-terc-butilbenziltio)-4-hlorpiridazīn-3(2H)-ons

405-700-3

96489-71-3

Acute Tox. 3

Acute Tox. 3

Aquatic Acute 1

Aquatic Chronic 1

H331

H301

H400

H410

GHS06

GHS09

Dgr

H331

H301

H410

M = 1 000

M = 1 000

Indeksa Nr.

Starptautiskā ķīmiskā identifikācija

EK Nr.

CAS Nr.

Klasifikācija

Marķējums

Specifiskās robežkoncentrācijas, m koeficients

Piezīmes

Bīstamības klases un kategorijas kodi

Bīstamības apzīmējuma kodi

Piktogramma, signālvārda kodi

Bīstamības apzīmējuma kodi

Papildu bīstamības apzīmējuma kodi

019-003-00-3

kālija (E,E)-heksa-2,4-dienoāts

246-376-1

24634-61-5

Eye Irrit. 2

H319

GSH07

Wng

H319

604-092-00-9

fenols, dodecil-, sazarotas virknes [1];

fenols, 2-dodecil-, sazarotas virknes;

fenols, 3-dodecil-, sazarotas virknes;

fenols, 4-dodecil-, sazarotas virknes;

fenols, (tetrapropenil) atvasinājumi [2]

310-154-3 [1]

121158-58-5 [1]

74499-35-7 [2]

Skin Corr. 1C

Aquatic Acute 1

Aquatic Chronic 1

H314

H400

H410

GHS05

GHS09

Dgr

H314

H410

M = 10

M = 10

606-148-00-8

karvons (ISO);

2-metil-5-(prop-1-en-2-il)cikloheks-2-en-1-ons; [1]

d-karvons; (5S)-2-metil-5-(prop-1-en-2-il)cikloheks-2-en-1-ons; [2]

l-karvons; (5R)-2-metil-5-(prop-1-en-2-il)cikloheks-2-en-1-ons [3]

202-759-5 [1]

218-827-2 [2]

229-352-5 [3]

99-49-0 [1]

2244-16-8 [2]

6485-40-1 [3]

Skin Sens. 1

H317

GHS07

Wng

H317

606-149-00-3

tembotrions (ISO); 2-{2-hlor-4-(metilsulfonil)-3-[(2,2,2-trifluoretoksi)metil]benzoil}cikloheksān-1,3-dions

—

335104-84-2

Repr. 2

STOT RE 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H361d

H373 (acis, nieres, aknas)

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H361d

H373 (acis, nieres, aknas)

H317

H410

M = 100

M = 10

607-707-00-9

fenoksaprop-P-etils (ISO); etil (2R)-2-{4-[(6-hlor-1,3-benzoksazol-2-il)oksi]fenoksi}propanoāts

—

71283-80-2

STOT RE 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H373 (nieres)

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H373 (nieres)

H317

H410

M = 1

M = 1

607-708-00-4

oktānskābe

204-677-5

124-07-2

Skin Corr. 1C

Aquatic Chronic 3

H314

H412

GHS05

Dgr

H314

H412

607-709-00-X

dekānskābe

206-376-4

334-48-5

Skin Irrit. 2

Eye Irrit. 2

Aquatic Chronic 3

H315

H319

H412

GHS07

Wng

H315

H319

H412

607-710-00-5

1,2-benzoldikarboksilskābe, diheksilesteris, sazarotas un lineāras virknes

271-093-5

68515-50-4

Repr. 1B

H360FD

GHS08

Dgr

H360FD

607-711-00-0

spirotetramats (ISO); (5 s,8 s)-3-(2,5-dimetilfenil)-8-metoksi-2-okso-1-azaspir[4,5]dec-3-en-4-il etilkarbonāts

—

203313-25-1

Repr. 2

STOT SE 3

Eye Irrit. 2

Skin Sens. 1A

Aquatic Acute 1

Aquatic Chronic 1

H361fd

H335

H319

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H361fd

H335

H319

H317

H410

M = 1

M = 1

607-712-00-6

dodemorfacetāts; 4-ciklododecil-2,6-dimetilmorfolīn-4-acetāts

250-778-2

31717-87-0

Repr. 2

STOT RE 2

Skin Corr. 1C

Skin Sens. 1A

Aquatic Chronic 1

H361d

H373 (aknas)

H314

H317

H410

GHS08

GHS05

GHS07

GHS09

Dgr

H361d

H373 (aknas)

H314

H317

H410

EUH071

M = 1

607-713-00-1

fenpiroksimāts (ISO); terc-butil 4-[({(E)-[(1,3-dimetil-5-fenoksi-1H-pirazol-4-il)metilēn]amino}oksi)metil]benzoāts

—

134098-61-6

Acute Tox. 3

Acute Tox. 2

Skin Sens. 1B

Aquatic Acute 1

Aquatic Chronic 1

H301

H330

H317

H400

H410

GHS06 GHS09

Dgr

H301

H330

H317

H410

M = 100

M = 1 000

607-714-00-7

triflusulfuronmetils; metil 2-({[4-(dimetilamino)-6-(2,2,2-trifluoretoksi)-1,3,5-triazin-2-il]karbamoil}sulfamoil)-3-metilbenzoāts

—

126535-15-7

Carc. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H400

H410

GHS08

GHS09

Wng

H351

H410

M = 100

M = 10

607-715-00-2

bifenazāts (ISO); izopropil 2-(4-metoksibifenil-3-il)hidrazīnkarboksilāts

442-820-5

149877-41-8

STOT RE 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H373

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H373

H317

H410

M = 1

M = 1

613-319-00-0

imidazols

206-019-2

288-32-4

Repr. 1B

Acute Tox. 4

Skin Corr. 1C

H360D

H302

H314

GHS08

GHS07

GHS05

Dgr

H360D

H302

H314

613-320-00-6

lenacils (ISO); 3-cikloheksil-6,7-dihidro-1H-ciklopenta[d]pirimidīn-2,4(3H,5H)-dions

218-499-0

2164-08-1

Carc. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H400

H410

GHS08

GHS09

Wng

H351

H410

M = 10

M = 10

616-213-00-2

mandipropamīds (ISO); 2-(4-hlorfenil)-N-{2-[3-metoksi-4-(prop-2-in-1-iloksi)fenil]etil}-2-(prop-2-in-1-iloksi)acetamīds

—

374726-62-2

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410

M = 1

M = 1

616-214-00-8

metosulams (ISO); N-(2,6-dihlor-3-metilfenil)-5,7-dimetoksi[1,2,4]triazol[1,5-a]pirimidīn-2-sulfonamīds

—

139528-85-1

Carc. 2

STOT RE 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H373 (acis, nieres)

H400

H410

GHS08

GHS09

Wng

H351

H373 (acis, nieres)

H410

M = 1 000

M = 100

616-215-00-3

dimetēnamīds-P (ISO); 2-hlor-N-(2,4-dimetil-3-tienil)-N-[(2S)-1-metoksipropan-2-il]acetamīds

—

163515-14-8

Acute Tox. 4

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

M = 10

M = 10

616-216-00-9

flonikamīds (ISO); N-(ciānmetil)-4-(trifluormetil)piridīn-3-karboksamīds

—

158062-67-0

Acute Tox. 4

H302

GHS07

Wng

H302

616-217-00-4

sulfoksaflors (ISO); [metil(okso){1-[6-(trifluormetil)-3-piridil]etil}-λ6-sulfanilidēn]ciānamīds

—

946578-00-3

Acute Tox. 4

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

M = 1

M = 1

Indeksa Nr.

Starptautiskā ķīmiskā identifikācija

EK Nr.

CAS Nr.

Klasifikācija

Marķējums

Robežkoncentrācijas

Piezīmes

007-004-00-1

… % slāpekļskābe

231-714-2

7697-37-2

O; R8

C; R35

O; C

R: 8-35

S: (1/2-)26-28- 36/37/39-45-63

O; R8: C ≥ 65 %

C; R35: C ≥ 20 %

C; R34: 5 % ≤ C < 20 %

B

015-003-00-2

kalcija fosfīds; trikalcija difosfīds

215-142-0

1305-99-3

F; R15/29

T+; R26/28

Xn; R21

R32

Xi; R38-41

N; R50

F; T+; N

R: 15/29-21-26/28-32-38-41-50

S:(1/2-)26-28-30-36/37/39-43-45-60-61

N; R50: C ≥ 0,25 %

031-001-00-4

gallija arsenīds

215-114-8

1303-00-0

Repr. Cat. 2; R60

Carc. Cat. 2; R45

T; R48/23

T

R: 45-48/23-60

S: 45-53

E

050-008-00-3

tributilalvas savienojumi, kas nav minēti citur šajā pielikumā

—

—

Repr. Cat. 2; R60-61

T; R25-48/23/25

Xn; R21

Xi; R36/38

N; R50-53

T; N

R: 21-25-36/38-48/23/25-50/53-60-61

S: 45-53-60-61

T; R25: C ≥ 2,5 %

Xn; R22: 0,25 % ≤ C < 2,5 %

Xn: R21: C ≥ 1 %

T; R48/23/25: C ≥ 1 %

Xn; R48/20/22: 0,25 % ≤ C < 1 %

Xi; R36/38: C ≥ 1 %

N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %

A

1

603-102-00-9

1,2-epoksibutāns

203-438-2

106-88-7

F; R11

Carc. Cat. 3; R40

Xn; R20/21/22

Xi; R36/37/38

F; Xn

R: 11-20/21/22-36/37/38-40-

S: (2-)9-16-29-36/37-46

603-197-00-7

tebukonazols (ISO); 1-(4-hlorfenil)-4,4-dimetil-3-(1,2,4-triazol-1-ilmetil)pentan-3-ols

403-640-2

107534-96-3

Repr. Cat. 3; R63

Xn; R22

N; R50-53

Xn; N

R: 22-50/53-63

S: (2-)22-36/37-60-61

N; R50-53: C ≥ 25 %

N; R51-53: 2,5 % ≤ C < 25 %

R52-53: 0,25 % ≤ C < 2,5 %

606-054-00-7

izoksaflutols (ISO); 5-ciklopropil-1,2-oksazol-4-il α, α,α-trifluor-2-mezil-p-tolilketons

—

141112-29-0

Repr. Cat. 3; R63

N; R50-53

Xn; N

R: 50/53-63

S: (2-)36/37-60-61

N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %

607-197-00-8

nonānskābe

203-931-2

112-05-0

Xi; R36/38

N; R51-53

Xi; N

R: 36/38-51/53

S: (2-)46-61

613-042-00-5

imazalils (ISO); 1-[2-(aliloksi)-2-(2,4-dihlorfenil)etil]-1H-imidazols

252-615-0

35554-44-0

Carc. Cat. 3; R40

Xn; R20/22

Xi; R41

N; R51-53

Xn; N

R: 20/22-40-41-51/53

S: (2-)26-36/37/39-46-61

613-057-00-7

dodemorfs (ISO); 4-ciklododecil-2,6-dimetilmorfolīns

216-474-9

1593-77-7

Repr. Cat. 3; R63

C; R34

R43

N; R50-53

C; N

R: 34-43-50/53-63

S: (1/2-)26-28-36/37/39-45-60-61

C; R34: C ≥ 10 %

Xi; R36/37/38: 5 % ≤ C < 10 %

N; R50-53: C ≥ 25 %

N; R51-53: 2,5 % ≤ C < 25 %

R52-53: 0,25 % ≤ C < 2,5 %

613-133-00-X

etridiazols (ISO); 5-etoksi-3-trihlormetil-1,2,4-tiadiazols

219-991-8

2593-15-9

Carc. Cat. 3; R40

Xn; R22

R43

N; R50-53

Xn; N

R: 22-40-43-50/53

S: (2-)36/37-46-60-61

N; R50-53: C ≥ 25 %

N; R51-53: 2,5 % ≤ C < 25 %

R52-53: 0,25 % ≤ C < 2,5 %

613-149-00-7

piridabēns (ISO); 2-terc-butil-5-(4-terc-butilbenziltio)-4-hlorpiridazīn-3(2H)-ons

405-700-3

96489-71-3

T; R23/25

N; R50-53

T; N

R: 23/25-50/53

S: (1/2-)36/37-45-60-61

N; R50-53: C ≥ 0,025 %

N; R51-53: 0,0025 % ≤ C < 0,025 %

R52-53: 0,00025 % ≤ C < 0,0025 %

Indeksa Nr.

Starptautiskā ķīmiskā identifikācija

EK Nr.

CAS Nr.

Klasifikācija

Marķējums

Robežkoncentrācijas

Piezīmes

019-003-00-3

kālija (E,E)-heksa-2,4-dienoāts

246-376-1

24634-61-5

Xi; R36

Xi

R: 36

S: (2-)25-46

604-092-00-9

fenols, dodecil-, sazarotas virknes [1];

fenols, 2-dodecil-, sazarotas virknes;

fenols, 3-dodecil-, sazarotas virknes;

fenols, 4-dodecil-, sazarotas virknes;

fenols, (tetrapropenil) atvasinājumi [2]

310-154-3 [1]-[2]

121158-58-5 [1]

74499-35-7 [2]

C; R34

N; R50-53

C; N

R: 34-50/53

S: (1/2-)26-36/37/39-45-61

N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %

606-148-00-8

karvons (ISO);

2-metil-5-(prop-1-en-2-il)cikloheks-2-en-1-ons; [1]

d-karvons; (5S)-2-metil-5-(prop-1-en-2-il)cikloheks-2-en-1-ons; [2]

l-karvons; (5R)-2-metil-5-(prop-1-en-2-il)cikloheks-2-en-1-ons [3]

202-759-5 [1]

218-827-2 [2]

229-352-5 [3]

99-49-0 [1]

2244-16-8 [2]

6485-40-1 [3]

R43

Xi

R: 43

S: (2-)24-37

606-149-00-3

tembotrions (ISO); 2-{2-hlor-4-(metilsulfonil)-3-[(2,2,2-trifluoretoksi)metil]benzoil}cikloheksān-1,3-dions

335104-84-2

Repr. Cat. 3; R63

Xn; R48/22

R43

N; R50-53

Xn; N

R: 43-48/22-50/53-63

S: (2-)36/37-46-60-61

N; R50-53: C ≥ 0,25 %

N; R51-53: 0,025 % ≤ C < 0,25 %

R52-53: 0,0025 % ≤ C < 0,025 %

607-707-00-9

fenoksaprop-P-etils (ISO); etil (2R)-2-{4-[(6-hlor-1,3-benzoksazol-2-il)oksi]fenoksi}propanoāts

—

71283-80-2

Xn; R48/22

R43

N; R50-53

Xn; N

R: 43-48/22-50/53

S: (2-)24-37-46-60-61

N; R50-53: C ≥ 25 %

N; R51-53: 2,5 % ≤ C < 25 %

R52-53: 0,25 % ≤ C < 2,5 %

607-708-00-4

oktānskābe

204-677-5

124-07-2

C; R34

N; R51-53

C; N

R: 34-51/53

S: (1/2-)26-36/37/39-45-61

607-709-00-X

dekānskābe

206-376-4

334-48-5

Xi; R36/38

N; R51-53

Xi; N

R: 36/38-51/53

S: (2-)25-46-61

607-710-00-5

1,2-benzoldikarboksilskābe, diheksilesteris, sazarotas un lineāras virknes

271-093-5

68515-50-4

Repr. Cat. 2; R60-61

T

R: 60-61

S: 53-45

607-711-00-0

spirotetramats (ISO); (5 s,8 s)-3-(2,5-dimetilfenil)-8-metoksi-2-okso-1-azaspir[4,5]dec-3-en-4-il etilkarbonāts

—

203313-25-1

Repr. Cat. 3; R62-63

Xi; R36/37

R43

N; R50-53

Xn; N

R: 36/37-43-50/53-62-63

S: (2-)36/37-60-61

Xi; R43: C ≥ 0,1 %

N; R50-53: C ≥ 25 %

N; R51-53: 2,5 % ≤ C < 25 %

R52-53: 0,25 % ≤ C < 2,5 %

607-712-00-6

dodemorfacetāts; 4-ciklododecil-2,6-dimetilmorfolīn-4-acetāts

250-778-2

31717-87-0

Repr. Cat. 3; R63

C; R34

R43

N; R51-53

C; N

R: 34-43-51/53-63

S: (1/2-)26-28-36/37/39-45-61

C; R34: C ≥ 10 %

Xi: R36/37/38: 5 % ≤ C < 10 %

607-713-00-1

fenpiroksimāts (ISO); terc-butil 4-[({(E)-[(1,3-dimetil-5-fenoksi-1H-pirazol-4-il)metilēn]amino}oksi)metil]benzoāts

—

134098-61-6

T+; R26

Xn; R22

R43

N; R50-53

T+; N

R: 22-26-43-50/53

S: (1/2-)28-36/37-45-60-61-63

N; R50-53: C ≥ 0,25 %

N; R51-53: 0,025 % ≤ C < 0,25 %

R52-53: 0,0025 % ≤ C < 0,025 %

607-714-00-7

triflusulfuronmetils; metil 2-({[4-(dimetilamino)-6-(2,2,2-trifluoretoksi)-1,3,5-triazin-2-il]karbamoil}sulfamoil)-3-metilbenzoāts

—

126535-15-7

Carc. Cat. 3; R40

N; R50-53

Xn; N

R: 40-50/53

S: (2-)36/37-60-61

N; R50-53: C ≥ 0,25 %

N; R51-53: 0,025 % ≤ C < 0,25 %

R52-53: 0,0025 % ≤ C < 0,025 %

607-715-00-2

bifenazāts (ISO); izopropil 2-(4-metoksibifenil-3-il)hidrazīnkarboksilāts

442-820-5

149877-41-8

R43

N; R50-53

Xi; N

R: 43-50/53

S: (2-)24-37-60-61

N; R50-53: C ≥ 25 %

N; R51-53: 2,5 % ≤ C < 25 %

R52-53: 0,25 % ≤ C < 2,5 %

613-319-00-0

imidazols

206-019-2

288-32-4

Repr. Cat 2; R61

Xn; R22

C; R34

T; C

R: 22-34-61

S: 53-45

613-320-00-6

lenacils (ISO); 3-cikloheksil-6,7-dihidro-1H-ciklopenta[d]pirimidīn-2,4(3H,5H)-dions

218-499-0

2164-08-1

Carc. Cat. 3; R40

N; R50-53

Xn; N

R: 40-50/53

S: (2-)36/37-60-61

N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %

616-213-00-2

mandipropamīds (ISO); 2-(4-hlorfenil)-N-{2-[3-metoksi-4-(prop-2-in-1-iloksi)fenil]etil}-2-(prop-2-in-1-iloksi)acetamīds

—

374726-62-2

N; R50-53

N

R: 50/53

S: 60-61

N; R50-53: C ≥ 25 %

N; R51-53: 2,5 % ≤ C < 25 %

R52-53: 0,25 % ≤ C < 2,5 %

616-214-00-8

metosulams (ISO); N-(2,6-dihlor-3-metilfenil)-5,7-dimetoksi[1,2,4]triazol[1,5-a]pirimidīn-2-sulfonamīds

—

139528-85-1

Carc. Cat. 3; R40

Xn; R48/22

N; R50-53

Xn; N

R: 40-48/22-50/53

S: (2-)36/37-46-60-61

N; R50-53: C ≥ 0,025 %

N; R51-53: 0,0025 % ≤ C < 0,025 %

R52/53: 0,00025 % ≤ C < 0,0025 %

616-215-00-3

dimetēnamīds-P (ISO); 2-hlor-N-(2,4-dimetil-3-tienil)-N-[(2S)-1-metoksipropan-2-il]acetamīds

—

163515-14-8

Xn; R22

R43

N; R50-53

Xn; N

R: 22-43-50/53

S: (2-)24-37-60-61

N; R50-53: C ≥ 2,5 %

N; R51-53: 0,25 % ≤ C < 2,5 %

R52-53: 0,025 % ≤ C < 0,25 %

616-216-00-9

flonikamīds (ISO); N-(ciānmetil)-4-(trifluormetil)piridīn-3-karboksamīds

—

158062-67-0

Xn; R22

Xn

R: 22

S: (2-)46

616-217-00-4

sulfoksaflors (ISO); [metil(okso){1-[6-(trifluormetil)-3-piridil]etil}-λ6-sulfanilidēn]ciānamīds

—

946578-00-3

Xn; R22

N; R50-53

Xn; N

R: 22-50/53

S: (2-)60-61

N; R50-53: C ≥ 25 %

N; R51-53: 2,5 % ≤ C < 25 %

R52-53: 0,25 % ≤ C < 2,5 %